REQUEST A DEMO
Total
USD $0.00
Search more companies

Interface Pharmaceuticals Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Interface Pharmaceuticals Pvt Ltd Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Interface Pharmaceuticals Pvt Ltd is an unlisted company, incorporated on 14/06/1999. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24232DL1999PTC100229 and registration number is 100229. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Ea-180, Maya Enclave
West Delhi; Delhi; Postal Code: 110064

Contact Details: Purchase the Interface Pharmaceuticals Pvt Ltd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Interface Pharmaceuticals Pvt Ltd report to view the information.
Registered Capital:
Purchase the Interface Pharmaceuticals Pvt Ltd report to view the information.
Incorporation Date:
June 14, 1999
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Interface Pharmaceuticals Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
4.54%
Total operating revenue
4.51%
Operating profit (EBIT)
11.36%
EBITDA
10.75%
Net Profit (Loss) for the Period
10.87%
Total assets
35.82%
Total equity
38.65%
Operating Profit Margin (ROS)
1.05%
Net Profit Margin
0.72%
Return on Equity (ROE)
-6.98%
Debt to Equity Ratio
-0.81%
Quick Ratio
1.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?